Insider Trading History of Girin Pascal E R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Girin Pascal E R since 2015. This trader's CIK number is 1329811. At the time of last reporting, Girin Pascal E R was the Officer of Clearpoint Neuro, Inc.. (stock ticker symbol CLPT). Also see all insider trading activities at Clearpoint Neuro, Inc..

Note that in the past Girin Pascal E R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Wright Medical Group Inc (WMGI) by Girin Pascal E R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 WMGI 0 $0 4,251 $110,955 0 $0

Yearly summary of insider trading at Clearpoint Neuro, Inc. (CLPT) by Girin Pascal E R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 CLPT 0 $0 0 $0 12,417 $0
2025 CLPT 0 $0 0 $0 21,093 $0
2024 CLPT 0 $0 0 $0 17,153 $0


Insider trading activities at 2 companies by Girin Pascal E R:

1. Wright Medical Group Inc (WMGI)

2. Clearpoint Neuro, Inc. (CLPT)

Table 1. Insider trading of Wright Medical Group Inc (WMGI) by Girin Pascal E R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-05-15 WMGI Sale 2,416 26.41 63,806
2015-05-14 WMGI Sale 1,405 25.65 36,038
2015-04-02 WMGI Sale 430 25.84 11,111

Table 2. Insider trading of Clearpoint Neuro, Inc. (CLPT) by Girin Pascal E R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-05-19 CLPT Option Ex 12,417 .00 0
2025-05-16 CLPT Option Ex 21,093 .00 0
2024-05-14 CLPT Option Ex 17,153 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Girin Pascal E R (Officer of Clearpoint Neuro, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.